Published in P R Health Sci J on March 01, 2010
Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch (1981) 134.60
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature (1998) 72.56
Single-channel currents recorded from membrane of denervated frog muscle fibres. Nature (1976) 13.78
Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J (2001) 12.88
On the stochastic properties of single ion channels. Proc R Soc Lond B Biol Sci (1981) 11.30
Structure and gating mechanism of the acetylcholine receptor pore. Nature (2003) 8.30
On the stochastic properties of bursts of single ion channel openings and of clusters of bursts. Philos Trans R Soc Lond B Biol Sci (1982) 7.45
Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci (2002) 5.87
Acetylcholine receptor channel imaged in the open state. Nature (1995) 5.27
Nicotinic acetylcholine receptor at 9 A resolution. J Mol Biol (1993) 4.96
Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol (2000) 4.04
Activation of ion channels in the frog end-plate by high concentrations of acetylcholine. J Physiol (1988) 3.19
Cloning and sequence analysis of calf cDNA and human genomic DNA encoding alpha-subunit precursor of muscle acetylcholine receptor. Nature (1983) 2.78
Mutation of the acetylcholine receptor alpha subunit causes a slow-channel myasthenic syndrome by enhancing agonist binding affinity. Neuron (1995) 2.55
Mutation in the M1 domain of the acetylcholine receptor alpha subunit decreases the rate of agonist dissociation. J Gen Physiol (1997) 2.25
The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. J Neurobiol (2002) 2.20
Staining for nerve fiber and cholinesterase activity in fresh frozen sections. Am J Clin Pathol (1967) 2.01
Identifying the lipid-protein interface of the Torpedo nicotinic acetylcholine receptor: secondary structure implications. Biochemistry (1994) 1.98
Congenital myasthenic syndrome caused by prolonged acetylcholine receptor channel openings due to a mutation in the M2 domain of the epsilon subunit. Proc Natl Acad Sci U S A (1995) 1.92
RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther (2005) 1.79
New mutations in acetylcholine receptor subunit genes reveal heterogeneity in the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1996) 1.60
Slow-channel myasthenic syndrome caused by enhanced activation, desensitization, and agonist binding affinity attributable to mutation in the M2 domain of the acetylcholine receptor alpha subunit. J Neurosci (1997) 1.59
A newly recognized congenital myasthenic syndrome attributed to a prolonged open time of the acetylcholine-induced ion channel. Ann Neurol (1982) 1.52
Functional architecture of the nicotinic acetylcholine receptor: a prototype of ligand-gated ion channels. J Membr Biol (1993) 1.34
Mutations in different functional domains of the human muscle acetylcholine receptor alpha subunit in patients with the slow-channel congenital myasthenic syndrome. Hum Mol Genet (1997) 1.33
The therapy of congenital myasthenic syndromes. Neurotherapeutics (2007) 1.29
Three-finger alpha-neurotoxins and the nicotinic acetylcholine receptor, forty years on. J Pharmacol Sci (2004) 1.27
Allele-specific silencing of a pathogenic mutant acetylcholine receptor subunit by RNA interference. Hum Mol Genet (2003) 1.23
Mapping the lipid-exposed regions in the Torpedo californica nicotinic acetylcholine receptor. Biochemistry (1992) 1.21
Molecular architecture of the neuromuscular junction. Muscle Nerve (2006) 1.16
The human muscle nicotinic acetylcholine receptor alpha-subunit exist as two isoforms: a novel exon. EMBO J (1990) 1.15
Primary structure of the human muscle acetylcholine receptor. cDNA cloning of the gamma and epsilon subunits. Eur J Biochem (1993) 1.14
Slow-channel mutation in acetylcholine receptor alphaM4 domain and its efficient knockdown. Ann Neurol (2006) 1.12
Congenital myasthenic syndromes. Curr Opin Neurol (2004) 1.08
Slow-channel transgenic mice: a model of postsynaptic organellar degeneration at the neuromuscular junction. J Neurosci (1997) 1.06
The human medulloblastoma cell line TE671 expresses a muscle-like acetylcholine receptor. Cloning of the alpha-subunit cDNA. FEBS Lett (1988) 1.05
Active calcium accumulation underlies severe weakness in a panel of mice with slow-channel syndrome. J Neurosci (2002) 1.05
Recessive inheritance and variable penetrance of slow-channel congenital myasthenic syndromes. Neurology (2002) 1.04
Chromosomal localization of muscle nicotinic acetylcholine receptor genes in the mouse. Science (1986) 0.99
Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome. Ann Neurol (1998) 0.98
A beta-subunit mutation in the acetylcholine receptor channel gate causes severe slow-channel syndrome. Ann Neurol (1996) 0.98
Discordant phenotype of two overlapping deletions involving the PAX3 gene in chromosome 2q35. Hum Mol Genet (1993) 0.98
Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms. Ann Neurol (2002) 0.98
Congenital myasthenic syndromes: recent advances. Arch Neurol (1999) 0.96
Nucleotide sequence of human muscle acetylcholine receptor beta-subunit. Nucleic Acids Res (1989) 0.95
Treatment of slow-channel congenital myasthenic syndrome with fluoxetine. Neurology (2003) 0.93
The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background. Histochem J (1993) 0.92
Focal caspase activation underlies the endplate myopathy in slow-channel syndrome. Ann Neurol (2004) 0.92
The slow channel syndrome. Two new cases. Brain (1987) 0.92
Quinidine normalizes the open duration of slow-channel mutants of the acetylcholine receptor. Neuroreport (1998) 0.92
Calpain activation impairs neuromuscular transmission in a mouse model of the slow-channel myasthenic syndrome. J Clin Invest (2007) 0.91
Effects of the quinoline derivatives quinine, quinidine, and chloroquine on neuromuscular transmission. Brain Res (1996) 0.91
Inositol-1,4,5-triphosphate receptors mediate activity-induced synaptic Ca2+ signals in muscle fibers and Ca2+ overload in slow-channel syndrome. Cell Calcium (2006) 0.90
A leucine-to-phenylalanine substitution in the acetylcholine receptor ion channel in a family with the slow-channel syndrome. Neurology (1995) 0.89
Long-term improvement of slow-channel congenital myasthenic syndrome with fluoxetine. Neuromuscul Disord (2006) 0.88
Congenital myasthenic syndromes. Semin Neurol (2004) 0.88
Activation of apoptotic pathways at muscle fiber synapses is circumscribed and reversible in a slow-channel syndrome model. Neurobiol Dis (2006) 0.87
AChR channel blockade by quinidine sulfate reduces channel open duration in the slow-channel congenital myasthenic syndrome. Ann N Y Acad Sci (1998) 0.84
Novel beta subunit mutation causes a slow-channel syndrome by enhancing activation and decreasing the rate of agonist dissociation. Mol Cell Neurosci (2006) 0.83
Developmental expression of nicotinic receptors in the chick and human spinal cord. J Comp Neurol (2003) 0.82
Linkage disequilibrium study of RFLPs detected at the human muscle nicotinic acetylcholine receptor subunit genes. Am J Hum Genet (1989) 0.81
Safety and efficacy of quinidine sulfate in slow-channel congenital myasthenic syndrome. Ann N Y Acad Sci (1998) 0.81
A transgenic mouse model of the slow-channel syndrome. Muscle Nerve (1996) 0.79
Congenital myasthenic syndromes. Neurol Clin (1994) 0.79
Desensitization of mutant acetylcholine receptors in transgenic mice reduces the amplitude of neuromuscular synaptic currents. Synapse (1997) 0.79
Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel. Ann Neurol (1998) 0.79
Calcium phosphate in osteogenic cells. A critique of the glyoxal bis(2-hydroxyanil) and the dilute silver acetate methods. Clin Orthop Relat Res (1970) 0.77
Macroscopic properties of spontaneous mutations in slow-channel syndrome: correlation by domain and disease severity. Synapse (2006) 0.76
Congenital myasthenic syndromes. Handb Clin Neurol (2008) 0.76
Local Transmission of Zika Virus - Puerto Rico, November 23, 2015-January 28, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.27
Guillain-Barré Syndrome During Ongoing Zika Virus Transmission - Puerto Rico, January 1-July 31, 2016. MMWR Morb Mortal Wkly Rep (2016) 0.95
Tryptophan-scanning mutagenesis in the alphaM3 transmembrane domain of the muscle-type acetylcholine receptor. A spring model revealed. J Biol Chem (2007) 0.93
Fourier transform coupled to tryptophan-scanning mutagenesis: lessons from its application to the prediction of secondary structure in the acetylcholine receptor lipid-exposed transmembrane domains. Biochim Biophys Acta (2008) 0.79
Tryptophan scanning of the acetylcholine receptor's betaM4 transmembrane domain: decoding allosteric linkage at the lipid-protein interface with ion-channel gating. Channels (Austin) (2008) 0.79
Epidermal innervation in healthy children and adolescents. Muscle Nerve (2015) 0.78
Fatal granulomatous meningoencephalitis associated to mycobacterium mucogenicum-like microorganism: a case report. P R Health Sci J (2009) 0.75